Challenges and opportunities in pharmacogenomics: studies in cardiovascular disease and asthma

Keyphrases

• Asthma 100%
• Cardiovascular Disease 100%
• Pharmacogenomic Studies 100%
• Pharmacogenomics 100%
• Pharmacogenetics 75%
• Statins 75%
• Genetic Variation 75%
• Common Disease 50%
• Drug Response 50%
• Pharmacogenetic Research 50%
• Pharmaceutical Companies 25%
• Combining Evidence 25%
• Polymorphism 25%
• Methodological Challenges 25%
• Clinical Practice 25%
• One-group 25%
• ACE Inhibitors 25%
• Diabetes 25%
• Gene Variation 25%
• Functional Impact 25%
• Human Disease 25%
• Lung Function 25%
• Broad Perspective 25%
• Multi-ethnic 25%
• Pharmacological Activities 25%
• General Introduction 25%
• Genetic Variability 25%
• Genetic Differences 25%
• Personalized Medicine 25%
• Disease Areas 25%
• Marketing Approval 25%
• Lack of Efficacy 25%
• Pharmacology 25%
• Pleadings 25%
• High Blood Pressure 25%
• Multiple Approaches 25%
• Tailored Treatment 25%
• Hypothesis-free 25%
• Non-replicating 25%
• Rare Variation 25%
• Statin Response 25%
• Gene Array 25%
• Number of Publications 25%
• Human Biology 25%
• False-positive Findings 25%
• Statin Potency 25%

Biochemistry, Genetics and Molecular Biology

• Pharmacogenetics 100%
• Pharmacogenetic Testing 100%
• Statin 100%
• Genetic Divergence 80%
• Pharmacogenomics 80%
• Genetic Variation 60%
• Genotyping 40%
• Genetics 20%
• Candidate Gene 20%
• DNA Microarray 20%
• Drug Mechanism 20%
• Sample Size 20%
• Blood Pressure 20%
• Drug Response 20%